Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients

被引:67
作者
Japiassu, Andre M. [1 ]
Amancio, Rodrigo T. [1 ]
Mesquita, Emerson C. [1 ]
Medeiros, Denise M. [1 ]
Bernal, Helena B. [2 ]
Nunes, Estevao P. [2 ]
Luz, Paula M. [2 ]
Grinsztejn, Beatriz [2 ]
Bozza, Fernando A. [1 ]
机构
[1] Fundacao Oswaldo Cruz, Intens Care Unit, Inst Pesquisa Clin Evandro Chagas, BR-21040360 Rio De Janeiro, Brazil
[2] Fundacao Oswaldo Cruz, HIV AIDS Res Ctr, Inst Pesquisa Clin Evandro Chagas, BR-21040360 Rio De Janeiro, Brazil
关键词
HIV-INFECTED PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; RIO-DE-JANEIRO; INTENSIVE-CARE; SEPTIC SHOCK; UNITED-STATES; SURVIVING SEPSIS; ORGAN FAILURE; SAPS-II; EPIDEMIOLOGY;
D O I
10.1186/cc9221
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: New challenges have arisen for the management of critically ill HIV/AIDS patients. Severe sepsis has emerged as a common cause of intensive care unit (ICU) admission for those living with HIV/AIDS. Contrastingly, HIV/AIDS patients have been systematically excluded from sepsis studies, limiting the understanding of the impact of sepsis in this population. We prospectively followed up critically ill HIV/AIDS patients to evaluate the main risk factors for hospital mortality and the impact of severe sepsis on the short-and long-term survival. Methods: All consecutive HIV-infected patients admitted to the ICU of an infectious diseases research center, from June 2006 to May 2008, were included. Severity of illness, time since AIDS diagnosis, CD4 cell count, antiretroviral treatment, incidence of severe sepsis, and organ dysfunctions were registered. The 28-day, hospital, and 6-month outcomes were obtained for all patients. Cox proportional hazards regression analysis measured the effect of potential factors on 28-day and 6-month mortality. Results: During the 2-year study period, 88 HIV/AIDS critically ill patients were admitted to the ICU. Seventy percent of patients had opportunist infections, median CD4 count was 75 cells/mm(3), and 45% were receiving antiretroviral therapy. Location on a ward before ICU admission, cardiovascular and respiratory dysfunctions on the first day after admission, and the presence of severe sepsis/septic shock were associated with reduced 28-day and 6-month survival on a univariate analysis. After a multivariate analysis, severe sepsis determined the highest hazard ratio (HR) for 28-day (adjusted HR, 3.13; 95% CI, 1.21-8.07) and 6-month (adjusted HR, 3.35; 95% CI, 1.42-7.86) mortality. Severe sepsis occurred in 44 (50%) patients, mainly because of lower respiratory tract infections. The survival of septic and nonseptic patients was significantly different at 28-day and 6-month follow-up times (log-rank and Peto test, P < 0.001). Conclusions: Severe sepsis has emerged as a major cause of admission and mortality for hospitalized HIV/AIDS patients, significantly affecting short-and longer-term survival of critically ill HIV/AIDS patients.
引用
收藏
页数:8
相关论文
共 51 条
  • [1] Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU - The PIP (Pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study
    Afessa, B
    Green, B
    [J]. CHEST, 2000, 118 (01) : 138 - 145
  • [2] Epidemiology of sepsis in the Valencian Community (Spain), 1995-2004
    Andreu Ballester, Juan Carlos
    Ballester, Ferran
    Gonzalez Sanchez, Antonio
    Almela Quilis, Amadeo
    Colomer Rubio, Enrique
    Penarroja Otero, Carlos
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (07) : 630 - 634
  • [3] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    Angus, DC
    Linde-Zwirble, WT
    Lidicker, J
    Clermont, G
    Carcillo, J
    Pinsky, MR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : 1303 - 1310
  • [4] Current epidemiology of septic shock - The CUB-Rea network
    Annane, D
    Aegerter, P
    Jars-Guincestre, MC
    Guidet, B
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (02) : 165 - 172
  • [5] [Anonymous], AIDS EP UPD 2009
  • [6] Trends in bloodstream infections among human immunodeficiency virus-infected adults admitted to a hospital in Nairobi, Kenya, during the last decade
    Arthur, G
    Nduba, VN
    Kariuki, SM
    Kimari, J
    Bhatt, SM
    Gilks, CF
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) : 248 - 256
  • [7] Promoting Global Research Excellence in Severe Sepsis (PROGRESS): Lessons from an International Sepsis Registry
    Beale, R.
    Reinhart, K.
    Brunkhorst, F. M.
    Dobb, G.
    Levy, M.
    Martin, G.
    Martin, C.
    Ramsey, G.
    Silva, E.
    Vallet, B.
    Vincent, J. -L.
    Janes, J. M.
    Sarwat, S.
    Williams, M. D.
    [J]. INFECTION, 2009, 37 (03) : 222 - 232
  • [8] Surviving sepsis in low-income and middle-income countries: new directions for care and research
    Becker, Joseph U.
    Theodosis, Christian
    Jacob, Shevin T.
    Wira, Charles R.
    Groce, Nora Ellen
    [J]. LANCET INFECTIOUS DISEASES, 2009, 9 (09) : 577 - 582
  • [9] Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study
    Blanco, Jesus
    Muriel-Bombin, Arturo
    Sagredo, Victor
    Taboada, Francisco
    Gandia, Francisco
    Tamayo, Luis
    Collado, Javier
    Garcia-Labattut, Angel
    Carriedo, Demetrio
    Valledor, Manuel
    De Frutos, Martin
    Lopez, Maria-Jesus
    Caballero, Ana
    Guerra, Jose
    Alvarez, Braulio
    Mayo, Agustin
    Villar, Jesus
    [J]. CRITICAL CARE, 2008, 12 (06)
  • [10] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655